Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13184)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 15, 2016 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pathophysiology
ISSN
2150-5330
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Alam S, Mustafa G, Alam M, Ahmad N. Insulin resistance in development and progression of nonalcoholic fatty liver disease. World J Gastrointest Pathophysiol 2016; 7(2): 211-217 [PMID: 27190693 DOI: 10.4291/wjgp.v7.i2.211] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i2/211.htm |
| Number | Citing Articles |
| 1 |
Zijian Sun, Binxia Chang, Miaomiao Gao, Jiyuan Zhang, Zhengsheng Zou. IL-33-ST2 Axis in Liver Disease: Progression and Challenge. Mediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/5314213
|
| 2 |
Sridhar Radhakrishnan, Jia-Yu Ke, Michael A Pellizzon. Targeted Nutrient Modifications in Purified Diets Differentially Affect Nonalcoholic Fatty Liver Disease and Metabolic Disease Development in Rodent Models. Current Developments in Nutrition 2020; 4(6): nzaa078 doi: 10.1093/cdn/nzaa078
|
| 3 |
Sugeedha Jeyapal, Suryam Reddy Kona, Surekha Venkata Mullapudi, Uday Kumar Putcha, Puvaneswari Gurumurthy, Ahamed Ibrahim. Substitution of linoleic acid with α-linolenic acid or long chain n-3 polyunsaturated fatty acid prevents Western diet induced nonalcoholic steatohepatitis. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-29222-y
|
| 4 |
Arash Karimi, Fatemeh Naeini, Hamid Reza Niazkar, Helda Tutunchi, Vali Musazadeh, Ata Mahmoodpoor, Vahid Asghariazar, Majid Mobasseri, Ali Tarighat-Esfanjani. Nano-curcumin supplementation in critically ill patients with sepsis: a randomized clinical trial investigating the inflammatory biomarkers, oxidative stress indices, endothelial function, clinical outcomes and nutritional status. Food & Function 2022; 13(12): 6596 doi: 10.1039/D1FO03746C
|
| 5 |
Kyungchul Song, Ho-Seong Kim, Hyun Wook Chae. Nonalcoholic fatty liver disease and insulin resistance in children. Clinical and Experimental Pediatrics 2023; 66(12): 512 doi: 10.3345/cep.2022.01312
|
| 6 |
Dong-Woo Lim, Hyuck Kim, Seung-Jun Lee, Ga-Ram Yu, Jai-Eun Kim, Won-Hwan Park. Jwa Kum Whan Attenuates Nonalcoholic Fatty Liver Disease by Modulating Glucose Metabolism and the Insulin Signaling Pathway. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/4589810
|
| 7 |
Muthukumaran Jayachandran, Shen Qu. Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies. Reviews in Endocrine and Metabolic Disorders 2023; 24(6): 1189 doi: 10.1007/s11154-023-09843-z
|
| 8 |
Rajib Das, Saikat Mitra, Abu Montakim Tareq, Talha Bin Emran, Md. Jamal Hossain, Ali M. Alqahtani, Yahia Alghazwani, Kuldeep Dhama, Jesus Simal-Gandara. Medicinal plants used against hepatic disorders in Bangladesh: A comprehensive review. Journal of Ethnopharmacology 2022; 282: 114588 doi: 10.1016/j.jep.2021.114588
|
| 9 |
Qin Yi, Puyang Sun, Juan Li, Siming Kong, Jinying Tian, Xuechen Li, Yanan Yang, Peicheng Zhang, Yuying Liu, Jingyan Han, Xiaolin Zhang, Fei Ye. Rho, a Fraction From Rhodiola crenulate, Ameliorates Hepatic Steatosis in Mice Models. Frontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.00222
|
| 10 |
Nada Pejnovic, Ilija Jeftic, Nemanja Jovicic, Nebojsa Arsenijevic, Miodrag L Lukic. Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis. World Journal of Gastroenterology 2016; 22(44): 9706-9717 doi: 10.3748/wjg.v22.i44.9706
|
| 11 |
Grietje Prins, Theerut Luangmonkong, Dorenda Oosterhuis, Henricus Mutsaers, Frank Dekker, Peter Olinga. A Pathophysiological Model of Non-Alcoholic Fatty Liver Disease Using Precision-Cut Liver Slices. Nutrients 2019; 11(3): 507 doi: 10.3390/nu11030507
|
| 12 |
Bo Ye, Jing Zhang, Zeyu Tan, Jiangang Chen, Xinliang Pan, Yuan Zhou, Wanwan Wang, Longlong Liu, Wenfei Zhu, Yuliang Sun, Ke Ning, Qian Xie, Ronghua Liu. Association of liver function with health-related physical fitness: a cross-sectional study. BMC Public Health 2023; 23(1) doi: 10.1186/s12889-023-16701-9
|
| 13 |
Seyed Mostafa Parizadeh, Seyed Alireza Parizadeh, Mohadese Alizade-Noghani, Reza Jafarzadeh-Esfehani, Maryam Ghandehari, Ali Mottaghi-Moghaddam, Fatemeh Goldani, Majid Khazaei, Majid Ghayour-Mobarhan, Gordon A. Ferns, Seyed Mahdi Hassanian, Amir Avan. Association between non-alcoholic fatty liver disease and colorectal cancer. Expert Review of Gastroenterology & Hepatology 2019; 13(7): 633 doi: 10.1080/17474124.2019.1617696
|
| 14 |
Valerio Rosato, Mario Masarone, Marcello Dallio, Alessandro Federico, Andrea Aglitti, Marcello Persico. NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome. International Journal of Environmental Research and Public Health 2019; 16(18): 3415 doi: 10.3390/ijerph16183415
|
| 15 |
Federica Perazza, Laura Leoni, Santo Colosimo, Alessandra Musio, Giulia Bocedi, Michela D’Avino, Giulio Agnelli, Alba Nicastri, Chiara Rossetti, Federica Sacilotto, Giulio Marchesini, Maria Letizia Petroni, Federico Ravaioli. Metformin and the Liver: Unlocking the Full Therapeutic Potential. Metabolites 2024; 14(4): 186 doi: 10.3390/metabo14040186
|
| 16 |
Mohammad Sultan Alakhali, Sadeq Ali Al-Maweri, Hashem Motahir Al-Shamiri, Khaled Al-haddad, Esam Halboub. The potential association between periodontitis and non-alcoholic fatty liver disease: a systematic review. Clinical Oral Investigations 2018; 22(9): 2965 doi: 10.1007/s00784-018-2726-1
|
| 17 |
Kyungchul Song, Juyeon Yang, Hye Sun Lee, Su Jin Kim, Myeongseob Lee, Junghwan Suh, Ahreum Kwon, Ho-Seong Kim, Hyun Wook Chae. Changes in the Prevalences of Obesity, Abdominal Obesity, and Non-Alcoholic Fatty Liver Disease among Korean Children during the COVID-19 Outbreak. Yonsei Medical Journal 2023; 64(4): 269 doi: 10.3349/ymj.2022.0540
|
| 18 |
Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Su Jin Chung, Sun Young Yang, Joo Sung Kim. Associations between White Blood Cell Count and the Development of Incidental Nonalcoholic Fatty Liver Disease. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/7653689
|
| 19 |
Kyungchul Song, Goeun Park, Hye Sun Lee, Myeongseob Lee, Hae In Lee, Han Saem Choi, Junghwan Suh, Ahreum Kwon, Ho-Seong Kim, Hyun Wook Chae. Comparison of the Triglyceride Glucose Index and Modified Triglyceride Glucose Indices to Predict Nonalcoholic Fatty Liver Disease in Youths. The Journal of Pediatrics 2022; 242: 79 doi: 10.1016/j.jpeds.2021.11.042
|
| 20 |
Kyungchul Song, Goeun Park, Hye Sun Lee, Myeongseob Lee, Hae In Lee, Jungmin Ahn, Eunbyoul Lee, Han Saem Choi, Junghwan Suh, Ahreum Kwon, Ho-Seong Kim, Hyun Wook Chae. Trends in Prediabetes and Non-Alcoholic Fatty Liver Disease Associated with Abdominal Obesity among Korean Children and Adolescents: Based on the Korea National Health and Nutrition Examination Survey between 2009 and 2018. Biomedicines 2022; 10(3): 584 doi: 10.3390/biomedicines10030584
|
| 21 |
Mayumi Nagashimada, Tsuguhito Ota. Role of vitamin E in nonalcoholic fatty liver disease. IUBMB Life 2019; 71(4): 516 doi: 10.1002/iub.1991
|
| 22 |
Meng-Juan Wu, Chen Yuan, Lin-Lin Lu, Bai-Quan An, Shi-Ying Xuan, Yong-Ning Xin. Role of NCAN rs2228603 polymorphism in the incidence of nonalcoholic fatty liver disease: a case-control study. Lipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0367-4
|
| 23 |
Ian James Martins. Nonalcoholic Fatty Liver Disease - An Update. 2019; doi: 10.5772/intechopen.81297
|
| 24 |
Masoumeh Atefi, Mohammad Hassan Entezari, Hamid Vahedi. The effects of sesame oil consumption on fatigue and mental health status in women with nonalcoholic fatty liver disease: a randomized, double-blinded, controlled trial. Nutrition & Food Science
2023; 53(7): 1207 doi: 10.1108/NFS-12-2022-0407
|
| 25 |
Jing Xu, Liangqin Gao, Huiqing Liang, Shaoliang Zhang, Penghua Lai, Shaodong Chen. Evidence for the anti-NAFLD effectiveness of chlorogenic acid as a HAT inhibitor using in vivo experiments supported by virtual molecular docking. Phytomedicine Plus 2021; 1(4): 100055 doi: 10.1016/j.phyplu.2021.100055
|
| 26 |
Xiao-lin Zhang, Ya-nan Wang, Lu-yao Ma, Zhong-sheng Liu, Fei Ye, Jian-hong Yang. Uncarboxylated osteocalcin ameliorates hepatic glucose and lipid metabolism in KKAy mice via activating insulin signaling pathway. Acta Pharmacologica Sinica 2020; 41(3): 383 doi: 10.1038/s41401-019-0311-z
|
| 27 |
Kyungchul Song, Nak-Hoon Son, Dong Ryul Chang, Hyun Wook Chae, Hyun Joo Shin. Feasibility of Ultrasound Attenuation Imaging for Assessing Pediatric Hepatic Steatosis. Biology 2022; 11(7): 1087 doi: 10.3390/biology11071087
|
| 28 |
Victory Okpujie, Opeyemi Tobalesi, Fidelis Uwumiro, Amaka C Ugoh, Elsie O Osiogo, Olawale Abesin, Oluwatobi A Olaomi, Chimaobi O Nwevo, Tosin Ayantoyinbo, Franklin Ejeagha. The Influence of Insulin Resistance on Outcomes in Hospitalizations for Alcohol-Related Liver Disease: A Nationwide Study. Cureus 2023; doi: 10.7759/cureus.42964
|
| 29 |
Margaryta Khomenko. CYTOKERATIN-18 AS A MARKER OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OBESE ADOLESCENTS. EUREKA: Health Sciences 2020; 5: 28 doi: 10.21303/2504-5679.2020.001415
|
| 30 |
Giuseppe Della Pepa, Claudia Vetrani, Gianluca Lombardi, Lutgarda Bozzetto, Giovanni Annuzzi, Angela Rivellese. Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals. Nutrients 2017; 9(10): 1065 doi: 10.3390/nu9101065
|
| 31 |
Baran Ghezelbash, Nader Shahrokhi, Mohammad Khaksari, Gholamreza Asadikaram, Maryam Shahrokhi, Sara Shirazpour. Protective Roles of Shilajit in Modulating Resistin, Adiponectin, and Cytokines in Rats with Non-alcoholic Fatty Liver Disease. Chinese Journal of Integrative Medicine 2022; 28(6): 531 doi: 10.1007/s11655-022-3307-3
|
| 32 |
Mandeep Kumar Singh, Bhrigu Kumar Das, Sandeep Choudhary, Deepak Gupta, Umesh K Patil. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management. Biomedicine & Pharmacotherapy 2018; 106: 991 doi: 10.1016/j.biopha.2018.06.095
|
| 33 |
Ghazaleh Pourali, Zeinab S. Hosseini, Mina Maftooh, Elham Nazari, Majid Khazaei, Mohammadreza Nassiri, Seyed M. Hassanian, Majid Ghayour-Mobarhan, Gordon A. Ferns, Mohammad A. Kiani, Amir Avan. Therapeutic Potential of Herbal Medicine against Non-alcoholic Fatty
Liver Disease. Current Drug Targets 2023; 24(4): 300 doi: 10.2174/1389450124666230113150116
|
| 34 |
Sutharinee Likitnukul, Sumpun Thammacharoen, Orada Sriwatananukulkit, Chanathip Duangtha, Ruedee Hemstapat, Chotchanit Sunrat, Supachoke Mangmool, Darawan Pinthong. Short-Term Growth Hormone Administration Mediates Hepatic Fatty Acid Uptake and De Novo Lipogenesis Gene Expression in Obese Rats. Biomedicines 2023; 11(4): 1050 doi: 10.3390/biomedicines11041050
|
| 35 |
Ali Kermanizadeh, Jessica Valli, Katarzyna Sanchez, Simon Hutter, Agnieszka Pawlowska, Graeme Whyte, Wolfgang Moritz, Vicki Stone. Particulate and drug-induced toxicity assessed in novel quadruple cell human primary hepatic disease models of steatosis and pre-fibrotic NASH. Archives of Toxicology 2022; 96(1): 287 doi: 10.1007/s00204-021-03181-2
|
| 36 |
Akshata Gandhe, Sonia Kumari, Masilamani Elizabeth Sobhia. Rational design of FXR agonists: a computational approach for NASH therapy. Molecular Diversity 2023; doi: 10.1007/s11030-023-10766-9
|
| 37 |
Rafael García-Carretero, Roberto Holgado-Cuadrado, Óscar Barquero-Pérez. Assessment of Classification Models and Relevant Features on Nonalcoholic Steatohepatitis Using Random Forest. Entropy 2021; 23(6): 763 doi: 10.3390/e23060763
|
| 38 |
Jinfei Yang, Weiwei Yao, Huihui Yang, Yajing Shen, Yuanyuan Zhang. Design and synthesis of ERα agonists: Effectively reduce lipid accumulation. Frontiers in Chemistry 2022; 10 doi: 10.3389/fchem.2022.1104249
|
| 39 |
Hannah E. Da Silva, Anastasia Teterina, Elena M. Comelli, Amel Taibi, Bianca M. Arendt, Sandra E. Fischer, Wendy Lou, Johane P. Allard. Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-19753-9
|
| 40 |
Mirza Alimullah, Asif Ul Haque Shuvo, Ishrat Jahan, Iffat Nowshin Ismail, S.M. Mufidul Islam, Mahnaj Sultana, Mahmudur Rahman Saad, Sabbir Raihan, Ferdous Khan, Md. Ashraful Alam, Nusrat Subhan. Evaluation of the modulating effect of epidermal growth factor receptor inhibitor cetuximab in carbon-tetrachloride induce hepatic fibrosis in rats. Biochemistry and Biophysics Reports 2024; 38: 101689 doi: 10.1016/j.bbrep.2024.101689
|
| 41 |
Shahinul Alam, Thupten Kelsang Lama, Golam Mustafa, Mahabubul Alam, Nooruddin Ahmad. Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment. 2018; doi: 10.5772/intechopen.71159
|
| 42 |
Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction. International Journal of Molecular Sciences 2019; 20(23): 5920 doi: 10.3390/ijms20235920
|
| 43 |
Athanasia Mitsala, Christos Tsalikidis, Konstantinos Romanidis, Michail Pitiakoudis. Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep’s Clothing?. Current Oncology 2022; 29(7): 4478 doi: 10.3390/curroncol29070356
|
| 44 |
Mei Guo. Cellular senescence and liver disease: Mechanisms and therapeutic strategies. Biomedicine & Pharmacotherapy 2017; 96: 1527 doi: 10.1016/j.biopha.2017.11.075
|
| 45 |
Zili Zhang, Zhen Yao, Yifan Chen, Lei Qian, Shuoyi Jiang, Jingyi Zhou, Jiangjuan Shao, Anping Chen, Feng Zhang, Shizhong Zheng. Lipophagy and liver disease: New perspectives to better understanding and therapy. Biomedicine & Pharmacotherapy 2018; 97: 339 doi: 10.1016/j.biopha.2017.07.168
|
| 46 |
Shahinul Alam. Past, Present, and Future of Hepatitis B and Fatty Liver in Bangladesh. Gastroenterology & Hepatology: Open Access 2017; 6(3) doi: 10.15406/ghoa.2017.06.00197
|
| 47 |
Fang-Zhou Ye, Wen-Yue Liu, Kenneth I. Zheng, Xiao-Yan Pan, Hong-Lei Ma, Xiao-Dong Wang, Yong-Ping Chen, Ming-Hua Zheng. Homeostatic model assessment of insulin resistance closely related to lobular inflammation in nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2020; 32(1): 80 doi: 10.1097/MEG.0000000000001483
|
| 48 |
Xinchi Wu, Juan Xu. New Role of Hispidulin in Lipid Metabolism: PPARα Activator. Lipids 2016; 51(11): 1249 doi: 10.1007/s11745-016-4200-7
|
| 49 |
Helda Tutunchi, Fatemeh Naeini, Majid Mobasseri, Alireza Ostadrahimi. Triglyceride glucose (TyG) index and the progression of liver fibrosis: A cross-sectional study. Clinical Nutrition ESPEN 2021; 44: 483 doi: 10.1016/j.clnesp.2021.04.025
|
| 50 |
Shahinul Alam, Shah Mohammad Fahim, Muhammad Abdul Baker Chowdhury, Md. Zakiul Hassan, Golam Azam, Golam Mustafa, Mainul Ahsan, Nooruddin Ahmad. Prevalence and risk factors of non‐alcoholic fatty liver disease in Bangladesh. JGH Open 2018; 2(2): 39 doi: 10.1002/jgh3.12044
|
| 51 |
Rafael Garcia-Carretero, Luis Vigil-Medina, Oscar Barquero-Perez, Javier Ramos-Lopez. Relevant Features in Nonalcoholic Steatohepatitis Determined Using Machine Learning for Feature Selection. Metabolic Syndrome and Related Disorders 2019; 17(9): 444 doi: 10.1089/met.2019.0052
|
| 52 |
Catherine Yzydorczyk, Na Li, Eve Rigal, Hassib Chehade, Dolores Mosig, Jean Baptiste Armengaud, Thibaud. Rolle, Anithan Krishnasamy, Eulalia Orozco, Benazir Siddeek, Christian Juvet, Catherine Vergely, Umberto Simeoni. Calorie Restriction in Adulthood Reduces Hepatic Disorders Induced by Transient Postnatal Overfeeding in Mice. Nutrients 2019; 11(11): 2796 doi: 10.3390/nu11112796
|
| 53 |
Sergio Quesada-Vázquez, Marina Colom-Pellicer, Èlia Navarro-Masip, Gerard Aragonès, Josep M. Del Bas, Antoni Caimari, Xavier Escoté. Supplementation with a Specific Combination of Metabolic Cofactors Ameliorates Non-Alcoholic Fatty Liver Disease, Hepatic Fibrosis, and Insulin Resistance in Mice. Nutrients 2021; 13(10): 3532 doi: 10.3390/nu13103532
|
| 54 |
Sutharinee Likitnukul, Sumpun Thammacharoen, Orada Sriwatananukulkit, Chanathip Duangtha, Ruedee Hemstapat, Witchuda Saengsawang, Supachoke Mangmool, Darawan Pinthong. Beneficial Effects of Short-Term Growth Hormone Administration on Non-Alcoholic Fatty Liver Disease (NAFLD) in Obese Rats. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4115224
|
| 55 |
Noha El Nakeeb, Shereen A Saleh, Yasmine M Massoud, Ahmed Hussein, Rana Hamed. Serum ferritin as a non‐invasive marker in the prediction of hepatic fibrosis among Egyptian patients with non‐alcoholic fatty liver disease. JGH Open 2017; 1(3): 112 doi: 10.1002/jgh3.12019
|
| 56 |
Su Wang, Xiafei Hong, Zhigang Tu, Guoyue Yuan. Angiopoietin-like protein 8: An attractive biomarker for the evaluation of subjects with insulin resistance and related disorders. Diabetes Research and Clinical Practice 2017; 133: 168 doi: 10.1016/j.diabres.2017.08.025
|
| 57 |
Feryal Savari, Seyyed Ali Mard, Mohammad Badavi, Anahita Rezaie, Mohammad Kazem Gharib-Naseri. A new method to induce nonalcoholic steatohepatitis (NASH) in mice. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1041-x
|
| 58 |
Min-Yu Chung, Ji-Hye Song, Jinhyuk Lee, Eun Ju Shin, Jae Ho Park, Seung-Hyun Lee, Jin-Taek Hwang, Hyo-Kyoung Choi. Tannic acid, a novel histone acetyltransferase inhibitor, prevents non-alcoholic fatty liver disease both in vivo and in vitro model. Molecular Metabolism 2019; 19: 34 doi: 10.1016/j.molmet.2018.11.001
|
| 59 |
Phaniendra Alugoju, V. K. D. Krishna Swamy, Naga Venkata Anusha Anthikapalli, Tewin Tencomnao. Health benefits of astaxanthin against age-related diseases of multiple organs: A comprehensive review. Critical Reviews in Food Science and Nutrition 2023; 63(31): 10709 doi: 10.1080/10408398.2022.2084600
|
| 60 |
Amr Ali El-Sehrawy, Omnia State, Rasha Rizk Elzehery, Ahmed Salem Mohamed. Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Premenopausal Women with Metabolic Syndrome. Hormone and Metabolic Research 2021; 53(02): 100 doi: 10.1055/a-1341-9710
|
| 61 |
Reza Afarin, Fereshteh Aslani, Shahla Asadizade, Bahar Jaberian Asl, Mehrnoosh Mohammadi Gahrooie, Elham Shakerian, Akram Ahangarpour. The Effect of Lipopolysaccharide-Stimulated Adipose-Derived Mesenchymal Stem Cells on NAFLD Treatment in High-Fat Diet-Fed Rats. Iranian Journal of Pharmaceutical Research 2023; 22(1) doi: 10.5812/ijpr-134807
|
| 62 |
Pierre Poinsot, Sophie Collardeau Frachon, Lioara Restier, André Sérusclat, Mathilde Di Filippo, Sybil Charrière, Philippe Moulin, Alain Lachaux, Noel Peretti. Childhood/adult-onset lysosomal acid lipase deficiency: A serious metabolic and vascular phenotype beyond liver disease—four new pediatric cases. Journal of Clinical Lipidology 2017; 11(1): 167 doi: 10.1016/j.jacl.2016.11.008
|
| 63 |
Xuan Du, Can Cai, Jialing Yao, Youping Zhou, Huihong Yu, Wei Shen. Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD. Biochemical and Biophysical Research Communications 2017; 483(1): 409 doi: 10.1016/j.bbrc.2016.12.129
|
| 64 |
Feng Qiao, Kaiyu Fu, Qing Zhang, Li Liu, Ge Meng, Hongmei Wu, Yang Xia, Xue Bao, Yeqing Gu, Hongbin Shi, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Kaijun Niu. The association between missing teeth and non‐alcoholic fatty liver disease in adults. Journal of Clinical Periodontology 2018; 45(8): 941 doi: 10.1111/jcpe.12929
|
| 65 |
Shahinul Alam, Mohammad Eslam, Nazmul SKM Hasan, Kamrul Anam, Muhammad Abdul Baker Chowdhury, Md Abdullah Saeed Khan, Mohammad J Hasan, Rosmawati Mohamed. Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta‐analysis. JGH Open 2021; 5(11): 1236 doi: 10.1002/jgh3.12658
|